Pharmacoeconomic Factors Related to the Treatment of Schizophrenia
​​​​​
Volume 60
 1999
Supplement 3

 

3  J Clin Psychiatry/Volume 60, 1999/Supplement 03 :1999

[Full Text]

Articles   [top]

3  Outcome in Schizophrenia: Beyond Symptom Reduction [Free Access]

[Full Text]

9  Methods of Cost-Effectiveness Analysis in the Evaluation of New Antipsychotics: Implications for Schizophrenia Treatment [Free Access]

[Full Text]

16  Mental Health Care From the Public Perspective: The Texas Medication Algorithm Project [Free Access]

[Full Text]

22  Cost-Utility Analysis in Schizophrenia [Free Access]

[Full Text]

29  The Wisconsin Quality of Life Index: A Multidimensional Model for Measuring Quality of Life [Free Access]

[Full Text]

32  Perspective and the Measurement of Costs and Benefits for Cost-Effectiveness Analysis in Schizophrenia [Free Access]

[Full Text]

38  What About the Patient? [Free Access]

[Full Text]

42  The Risperidone Outcomes Study of Effectiveness (ROSE): A Model for Evaluating Treatment Strategies in Typical Psychiatric Practice [Free Access]

[Full Text]

49  Cost of Treating Mental Illness From a Managed Care Perspective [Free Access]

[Full Text]

54  Panel on Cost-Effectiveness in Health and Medicine Recommendations: Identifying Costs [Free Access]

[Full Text]

59  Concluding Discussion [Free Access]

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx